Sonoma Pharmaceuticals and EMC Pharma have entered into a co-marketing agreement to expand their eye care product lines, according to a press release.
Through the agreement, EMC will have the right to sell Sonoma’s over-the-counter Ocucyn (0.01% hypochlorous acid), and Sonoma will sell EMC’s prescription Acuicyn hypochlorous acid-based eyelid and eyelash cleanser, according to the release.
Ocucyn is designed for daily use to reduce itch and irritation, while Acuicyn is used to manage conditions such as dry eye disease and blepharitis. The companies plan to present the products at